Patent classifications
B01J31/2295
Ruthenium complex containing alkynyl group, method of synthesizing the same and use thereof
A Ruthenium complex containing alkynyl group, a method of synthesizing the Ruthenium complex containing alkynyl group and a use thereof are provided. The Ruthenium complex has a chemical formula of Ru(L).sub.2(DPPZ′). DPPZ′ is a main ligand having structural formula of ##STR00001##
R is any one selected from the group consisting of H, substituted or unsubstituted phenyl, R.sub.1NH.sub.2, R.sub.1OH, and SiMe.sub.3; R.sub.1 is C1-C5 chain alkyl group; L is an auxiliary ligand with N as coordinating atom. Sonogashira coupling reaction is utilized to introduce alkynyl group into a DPPZ-type Ruthenium complex; the introduced alkynyl group is beneficial to promote the transmembrane absorption of drug molecules, increase the probability of drug entry into cells, and can also increase efficacy and reduce toxic and side effects of drugs. The Ruthenium complex provided has significant anti-tumor activity, especially anti-breast cancer activity, and can provide new ideas for designing anti-tumor drug molecules in the future.
Method for producing alpha-fluoroacrylic acid
An object of the present invention is to provide a novel method for producing an α-fluoroacrylic acid ester compound. ##STR00001##
This problem is solved by a method for producing a compound represented by formula (1), wherein R.sup.1 and R.sup.2 are identical or different, and each represents an alkyl group or the like; and R.sup.3 is an alkyl group or the like, the method comprising step A of reacting a compound represented by formula (2) with R.sup.3—OH (3) and carbon monoxide in the presence of palladium, a double bond-containing compound (α), a diphosphine compound (β), and a base, to obtain the compound represented by formula (1) above.
Catalyst for asymmetric hydrogenation of compound containing carbon double bond
The present invention may provide an asymmetric hydrogenation catalyst capable of resolving enantiomers with excellent enantioselectivity from a carbon-carbon double bond-containing compound. The catalyst according to one embodiment of the present invention includes: an iridium cation; and a ligand bonded to the iridium cation.
METHOD OF MAKING METAL-LIGAND COMPLEXES
Embodiments of the present disclosure are directed towards method of making a metal-ligand complex, the method including: reacting a (L.sup.1)H compound and a base in a primary solvent to make a reaction mixture comprising an intermediate anionic L.sup.1 compound in the primary solvent; and reacting the intermediate anionic L.sup.1 compound and a L.sup.2MX.sub.3 complex to make a L.sup.1L.sup.2MX.sub.2 complex, wherein L.sup.1 and L.sup.2 independently are cyclopentadienyl-type (Cp-type) ligands, M is zirconium or hafnium, and each X is a halide and wherein the intermediate anionic L.sup.1 compound is not isolated from the reaction mixture.
Process for the preparation of enantiomerically pure norepinephrine
The invention concerns a new, efficient process for the preparation of enantiomerically pure norepinephrine (also known as noradrenaline), or an addition salt thereof, using a catalytic hydrogenation system under hydrogen donor transfer. The invention also discloses a novel intermediate and the process for the preparation thereof.
Method for converting hydroxyl group of alcohol
The present invention relates to: a method for converting a hydroxyl group of an alcohol; and a catalyst which makes the method possible. A method for converting a hydroxyl group of an alcohol according to the present invention is characterized by producing a compound represented by CH(R.sup.1)(R.sup.2)Nu (wherein R.sup.1, R.sup.2 and Nu are as defined below) by reacting an alcohol represented by CH(R.sup.1)(R.sup.2)OH (wherein each of R.sup.1 and R.sup.2 represents a hydrogen atom, an optionally substituted alkyl group, or the like) and a compound having an active proton, which is represented by H-Nu (wherein Nu represents a group represented by —CHX.sup.1-EWG.sup.1 or —NR.sup.3R.sup.4; X.sup.1 represents a hydrogen atom or the like; EWG.sup.1 represents an electron-withdrawing group; and each of R.sup.3 and R.sup.4 represents a hydrogen atom, an optionally substituted alkyl group, or the like), with each other in the presence of a complex of a group 7-11 metal of the periodic table and at least one solid base that is selected from the group consisting of layered double hydroxides, composite oxides and calcium hydroxide.
Arene-immobilized ru(II)TsDPEN complexes: synthesis and applications to the asymetric transfer hydrogenation of ketones
Arene-immobilized Ru(II)TsDPEN Noyori-Ikariya catalysts anchored to silica through the coordinated η6-arene are provided. The catalysts efficiently catalyze many reactions, including the asymmetric transfer hydrogenation of ketones to alcohols.
NOVEL METAL COMPLEX, METHOD FOR PRODUCING SAME, AND METHOD FOR PRODUCING GAMMA-LACTAM COMPOUND USING SAME
The present invention relates to a novel metal complex, a method for producing same, and a method for producing a gamma-lactam compound using same, and the metal complex according to the present invention is used as a catalyst for producing a gamma-lactam compound and can efficiently produce a gamma-lactam compound with an excellent yield and excellent selectivity.
SYSTEM AND METHOD OF PRODUCING CARBON NANOTUBES
A system and method of producing carbon nanotubes from flare gas and other gaseous carbon-containing sources.
Plasmonic assisted systems and methods for interior energy-activation from an exterior source
A method and a system for producing a change in a medium disposed in an artificial container. The method places in a vicinity of the medium at least one of a plasmonics agent and an energy modulation agent. The method applies an initiation energy through the artificial container to the medium. The initiation energy interacts with the plasmonics agent or the energy modulation agent to directly or indirectly produce the change in the medium. The system includes an initiation energy source configured to apply an initiation energy to the medium to activate the plasmonics agent or the energy modulation agent.